{
  "schemaVersion" : 2,
  "registerId" : "F2020L00825",
  "instrumentNumber" : "50/2020",
  "citation" : "Statement of Principles concerning retinal vascular occlusion (Reasonable Hypothesis) (No. 50 of 2020)",
  "conditionName" : "retinal vascular occlusion",
  "effectiveFrom" : "2020-07-27",
  "standardOfProof" : "Reasonable Hypothesis",
  "icdCodes" : [ {
    "version" : "ICD-10-AM",
    "code" : "H34"
  } ],
  "onsetFactors" : [ {
    "paragraph" : "9(1)",
    "text" : "having smoked at least ten pack-years of tobacco products before the\r\nclinical onset of retinal vascular occlusion, and where smoking has\r\npermanently ceased, the clinical onset of retinal vascular occlusion has\r\noccurred within ten years of cessation",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(2)",
    "text" : "having hypertension before the clinical onset of retinal vascular\r\nocclusion",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(3)",
    "text" : "having diabetes mellitus before the clinical onset of retinal vascular\r\nocclusion",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(4)",
    "text" : "being obese for at least five years within the 15 years before the\r\nclinical onset of retinal vascular occlusion",
    "definedTerms" : [ {
      "term" : "being obese",
      "definition" : "means having a Body Mass Index (BMI) of 30 or greater.\r\nNote: BMI is also defined in the Schedule 1 - Dictionary."
    } ]
  }, {
    "paragraph" : "9(5)",
    "text" : "having dyslipidaemia before the clinical onset of retinal vascular\r\nocclusion",
    "definedTerms" : [ {
      "term" : "dyslipidaemia",
      "definition" : "means persistently abnormal blood lipid levels, diagnosed by a\r\nmedical practitioner and evidenced by:\r\n(a) a total serum cholesterol level greater than 5.5 mmol/L; or\r\n(b) a serum low density lipoprotein level greater than 4.0 mmol/L; or\r\n(d) a serum triglyceride level greater than or equal to 2.0 mmol/L; or\r\n(e) the regular administration of drug therapy to normalise blood lipid\r\nlevels."
    } ]
  }, {
    "paragraph" : "9(6)",
    "text" : "having hyperhomocysteinaemia before the clinical onset of retinal\r\nvascular occlusion",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(7)",
    "text" : "having an arteritis from the specified list of systemic arteritides, at the\r\ntime of the clinical onset of retinal vascular occlusion",
    "definedTerms" : [ {
      "term" : "specified list of systemic arteritides",
      "definition" : "means:\r\n(a) giant cell (temporal) arteritis;\r\n(b) polyarteritis nodosa;\r\n(c) Takayasu arteritis; or\r\n(d) thromboangiitis obliterans (Buerger's disease)."
    } ]
  }, {
    "paragraph" : "9(8)",
    "text" : "having retinal vasculitis at the time of the clinical onset of retinal\r\nvascular occlusion",
    "definedTerms" : [ {
      "term" : "retinal vasculitis",
      "definition" : "means inflammation of the retinal artery or its branches, or\r\nthe retinal vein or its tributaries. Retinal vasculitis can be due to autoimmune\r\ndisease, infection, drugs, or may be idiopathic. It can be confined to the\r\nretinal vessels, or may be an element of a systemic vasculitis.\r\nNote 1: Autoimmune diseases that can cause  include:\r\n(a) Behcet disease;\r\n(b) eosinophilic granulomatosis with polyangiitis (EGPA);\r\n(c) granulomatosis with polyangiitis (Wegener granulomatosis);\r\n(d) microscopic polyangiitis;\r\n(e) polyarteritis nodosa;\r\n(f) Susac syndrome;\r\n(g) systemic lupus erythematosus; and\r\n(h) systemic sclerosis (scleroderma).\r\nNote 2: Infections that can cause  include:\r\n(a) cytomegalovirus;\r\n(b) herpes simplex virus;\r\n(c) human immunodeficiency virus;\r\n(d) syphilis;\r\n(e) toxoplasmosis;\r\n(f) tuberculosis;\r\n(g) varicella zoster virus; and\r\n(h) viral uveitis.\r\nNote 3: Drug-induced causes of  include intravitreal vancomycin and intraocular\r\ngentamycin."
    } ]
  }, {
    "paragraph" : "9(9)",
    "text" : "having a non-inflammatory vasculopathy of the cerebral or retinal\r\nvessels from the specified list of vasculopathies at the time of the\r\nclinical onset of retinal vascular occlusion",
    "definedTerms" : [ {
      "term" : "specified list of vasculopathies",
      "definition" : "means:\r\n(a) fibromuscular dysplasia;\r\n(b) Moyamoya disease; or\r\n(c) Sneddon syndrome."
    } ]
  }, {
    "paragraph" : "9(10)",
    "text" : "having a disorder that is associated with a hypercoagulable state or\r\nhyperviscosity at the time of the clinical onset of retinal vascular\r\nocclusion",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(11)",
    "text" : "having:\r\n(a) a benign or malignant neoplasm; or\r\n(b) a non-neoplastic mass lesion;\r\nwhich compresses or infiltrates the retinal vessels of the affected eye at\r\nthe time of the clinical onset of retinal vascular occlusion;\r\nNote 1: Examples of a benign or malignant neoplasm include astrocytoma, optic nerve\r\nmeningioma, leukaemia and lymphoma.\r\nNote 2: Examples of a non-neoplastic mass lesion include haematoma, sarcoidosis,\r\nneurofibromatosis and exophthalmos",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(12)",
    "text" : "having a vascular abnormality of the retinal vessels of the affected eye\r\nat the time of the clinical onset of retinal vascular occlusion",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(13)",
    "text" : "having migraine at the time of the clinical onset of retinal vascular\r\nocclusion",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(14)",
    "text" : "having infection with human immunodeficiency virus before the\r\nclinical onset of retinal vascular occlusion",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(15)",
    "text" : "having an ocular or orbital infection involving the affected eye within\r\nthe 30 days before the clinical onset of retinal vascular occlusion;\r\nNote 1: Examples of an ocular or orbital infection include:\r\n(a) cat scratch disease;\r\n(b) herpes zoster ophthalmicus;\r\n(c) ocular tuberculosis; and\r\n(d) orbital abscess or cellulitis.\r\nNote 2: This excludes isolated conjunctivitis or blepharitis of the affected eye",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(16)",
    "text" : "having direct external pressure to the eyeball of the affected eye for a\r\ncontinuous period of at least ten minutes, within the 24 hours before\r\nthe clinical onset of retinal vascular occlusion;\r\n(a) surgery in the prone position;\r\n(b) surgery involving the use of a device that compresses the eyes; and\r\n(c) positioning that places direct mechanical pressure on the eye",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(17)",
    "text" : "having a blunt or penetrating injury involving the affected eye or the\r\nblood vessels supplying or draining the affected eye, including surgery\r\nor a therapeutic procedure, within the seven days before the clinical\r\nonset of retinal vascular occlusion;\r\nNote 1: In the case of prolonged unconsciousness associated with trauma, the seven day period\r\nis taken to commence upon regaining consciousness.\r\nNote 2: Examples of blunt or penetrating injury include:\r\n(a) blunt trauma to the orbit;\r\n(b) eyeball contusion; and\r\n(c) intraocular foreign body.\r\nNote 3: Examples of surgery or a therapeutic procedure include:\r\n(a) cataract surgery;\r\n(b) filler injection to the forehead, or the glabellar, nasal or nasolabial fold regions;\r\n(c) intraocular or retrobulbar anaesthesia;\r\n(d) intravitreal bevacizumab injection; and\r\n(e) sclerotherapy of facial veins",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(18)",
    "text" : "taking a drug from the specified list of drugs within the 72 hours before\r\nthe clinical onset of retinal vascular occlusion",
    "definedTerms" : [ {
      "term" : "specified list of drugs",
      "definition" : "means:\r\n(a) amphetamines and amphetamine-like compounds;\r\n(b) cannabis;\r\n(c) intranasal cocaine;\r\n(d) intravenous heroin contaminated with talc;\r\n(e) phosphodiesterase type 5 (PDE5) inhibitors;\r\n(f) testosterone supplementation; or\r\n(g) tranexamic acid."
    } ]
  }, {
    "paragraph" : "9(19)",
    "text" : "taking a combined oral contraceptive pill for a continuous period of at\r\nleast 21 days within the one year before the clinical onset of retinal\r\nvascular occlusion",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(20)",
    "text" : "experiencing an acute hypotensive episode within the 24 hours before\r\nthe clinical onset of retinal vascular occlusion",
    "definedTerms" : [ {
      "term" : "acute hypotensive episode",
      "definition" : "means a sudden drop in blood pressure of a\r\nsufficient degree to cause cerebral hypoperfusion."
    } ]
  }, {
    "paragraph" : "9(21)",
    "text" : "for retinal venous occlusion only:\r\n(a) having open-angle glaucoma, angle-closure glaucoma or ocular\r\nhypertension, at the time of the clinical onset of retinal vascular\r\nocclusion;\r\n(b) having chronic renal failure at the time of the clinical onset of\r\nretinal vascular occlusion;\r\n(c) being severely dehydrated at the time of the clinical onset of\r\nretinal vascular occlusion; or\r\n(d) having obstructive sleep apnoea at the time of the clinical onset\r\nof retinal vascular occlusion",
    "definedTerms" : [ {
      "term" : "chronic renal failure",
      "definition" : "means:\r\n2\r\n(a) having a glomerular filtration rate of less than 15 mL/min/1.73 m for a\r\nperiod of at least three months; or\r\n(b) a need for renal replacement therapy (dialysis or transplantation) for\r\ntreatment of complications of decreased glomerular filtration rate\r\nwhich would otherwise increase the risk of morbidity and mortality; or\r\n(c) undergoing chronic dialysis.\r\ndisorder that is associated with a hypercoagulable state or hyperviscosity\r\nmeans an acquired defect in blood components that alters blood viscosity or\r\ndisrupts the coagulation cascade, characterised by an increased predisposition\r\nto form blood clots.\r\nNote: Examples of a disorder that is associated with a hypercoagulable state or hyperviscosity include:\r\n(a) antiphospholipid antibody syndrome;\r\n(b) lymphoplasmacytic leukaemia;\r\n(c) lymphoplasmacytic lymphoma (Waldenstrom macroglobulinaemia);\r\n(d) myeloma;\r\n(e) myeloproliferative neoplasm;\r\n(f) nephrotic syndrome;\r\n(g) paroxysmal nocturnal haemoglobinuria; and\r\n(h) polycythaemia."
    }, {
      "term" : "being severely dehydrated",
      "definition" : "means having clinical dysfunction due to\r\ninadequate body fluids, in which the loss of body fluids, mostly water,\r\nexceeds intake. Symptoms and signs of severe dehydration include limited\r\nor absent urine output, dizziness or lightheadedness, and orthostatic\r\nhypotension.\r\nNote: Examples of causes of dehydration include strenuous physical activity, vomiting, diarrhoea and\r\nfebrile illness."
    } ],
    "conditionVariant" : {
      "name" : "retinal venous occlusion",
      "variantFactors" : [ {
        "paragraph" : "(a)",
        "text" : "having open-angle glaucoma, angle-closure glaucoma or ocular\r\nhypertension, at the time of the clinical onset of retinal vascular\r\nocclusion"
      }, {
        "paragraph" : "(b)",
        "text" : "having chronic renal failure at the time of the clinical onset of\r\nretinal vascular occlusion"
      }, {
        "paragraph" : "(c)",
        "text" : "being severely dehydrated at the time of the clinical onset of\r\nretinal vascular occlusion"
      }, {
        "paragraph" : "(d)",
        "text" : "having obstructive sleep apnoea at the time of the clinical onset\r\nof retinal vascular occlusion"
      } ]
    }
  }, {
    "paragraph" : "9(22)",
    "text" : "for retinal arterial occlusion only:\r\n(a) having carotid artery disease at the time of the clinical onset of\r\nretinal vascular occlusion;\r\n(b) having a cardiac disease with the potential to give rise to a\r\nretinal embolus at the time of the clinical onset of retinal\r\nvascular occlusion;\r\n(a) acute myocardial infarction;\r\n(b) atrial fibrillation; and\r\n(c) mitral or aortic valve disease.\r\n(c) having a non-cardiac potential source of retinal embolus at the\r\ntime of the clinical onset of retinal vascular occlusion; or\r\n(a) aortic arch atherosclerosis;\r\n(b) atherosclerotic central retinal artery;\r\n(c) decompression sickness;\r\n(d) deep vein thrombosis in the presence of a potential route of paradoxical\r\nembolism;\r\n(e) pulmonary barotrauma; and\r\n(f) severe bone trauma.\r\n(d) undergoing a procedure to the heart or the carotid artery, or an\r\nintravascular procedure involving the vessels of the head or\r\nneck, within the seven days before the clinical onset of retinal\r\nvascular occlusion;\r\nNote 1: Examples of a procedure to the heart include:\r\n(a) cardiac surgery or cardiac catheterisation;\r\n(b) coronary angiography; and\r\n(c) coronary artery bypass grafting.\r\nNote 2: Examples of a procedure to the carotid artery include:\r\n(a) carotid angioplasty;\r\n(b) carotid endarterectomy; and\r\n(c) carotid stenting.\r\nNote 3: Examples of an intravascular procedure involving the vessels of the head or\r\nneck include:\r\n(a) cosmetic vein sclerotherapy to the orbital adnexa, face, nose or sinuses;\r\n(b) transcatheter thyroid artery embolisation; and\r\n(c) transfemoral cerebral angiography",
    "definedTerms" : [ ],
    "conditionVariant" : {
      "name" : "retinal arterial occlusion",
      "variantFactors" : [ {
        "paragraph" : "(a)",
        "text" : "having carotid artery disease at the time of the clinical onset of\r\nretinal vascular occlusion"
      }, {
        "paragraph" : "(b)",
        "text" : "having a cardiac disease with the potential to give rise to a\r\nretinal embolus at the time of the clinical onset of retinal\r\nvascular occlusion"
      }, {
        "paragraph" : "(a)",
        "text" : "acute myocardial infarction"
      }, {
        "paragraph" : "(b)",
        "text" : "atrial fibrillation; and"
      }, {
        "paragraph" : "(c)",
        "text" : "mitral or aortic valve disease."
      }, {
        "paragraph" : "(c)",
        "text" : "having a non-cardiac potential source of retinal embolus at the\r\ntime of the clinical onset of retinal vascular occlusion"
      }, {
        "paragraph" : "(a)",
        "text" : "aortic arch atherosclerosis"
      }, {
        "paragraph" : "(b)",
        "text" : "atherosclerotic central retinal artery"
      }, {
        "paragraph" : "(c)",
        "text" : "decompression sickness"
      }, {
        "paragraph" : "(d)",
        "text" : "deep vein thrombosis in the presence of a potential route of paradoxical\r\nembolism"
      }, {
        "paragraph" : "(e)",
        "text" : "pulmonary barotrauma; and"
      }, {
        "paragraph" : "(f)",
        "text" : "severe bone trauma."
      }, {
        "paragraph" : "(d)",
        "text" : "undergoing a procedure to the heart or the carotid artery, or an\r\nintravascular procedure involving the vessels of the head or\r\nneck, within the seven days before the clinical onset of retinal\r\nvascular occlusion;\r\nNote 1: Examples of a procedure to the heart include:"
      }, {
        "paragraph" : "(a)",
        "text" : "cardiac surgery or cardiac catheterisation"
      }, {
        "paragraph" : "(b)",
        "text" : "coronary angiography; and"
      }, {
        "paragraph" : "(c)",
        "text" : "coronary artery bypass grafting.\r\nNote 2: Examples of a procedure to the carotid artery include:"
      }, {
        "paragraph" : "(a)",
        "text" : "carotid angioplasty"
      }, {
        "paragraph" : "(b)",
        "text" : "carotid endarterectomy; and"
      }, {
        "paragraph" : "(c)",
        "text" : "carotid stenting.\r\nNote 3: Examples of an intravascular procedure involving the vessels of the head or\r\nneck include:"
      }, {
        "paragraph" : "(a)",
        "text" : "cosmetic vein sclerotherapy to the orbital adnexa, face, nose or sinuses"
      }, {
        "paragraph" : "(b)",
        "text" : "transcatheter thyroid artery embolisation; and"
      }, {
        "paragraph" : "(c)",
        "text" : "transfemoral cerebral angiography"
      } ]
    }
  } ],
  "aggravationFactors" : [ {
    "paragraph" : "9(23)",
    "text" : "having smoked at least ten pack-years of tobacco products before the\r\nclinical worsening of retinal vascular occlusion, and where smoking\r\nhas permanently ceased, the clinical worsening of retinal vascular\r\nocclusion has occurred within ten years of cessation",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(24)",
    "text" : "having hypertension before the clinical worsening of retinal vascular\r\nocclusion",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(25)",
    "text" : "having diabetes mellitus before the clinical worsening of retinal\r\nvascular occlusion",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(26)",
    "text" : "being obese for at least five years within the 15 years before the\r\nclinical worsening of retinal vascular occlusion",
    "definedTerms" : [ {
      "term" : "being obese",
      "definition" : "means having a Body Mass Index (BMI) of 30 or greater.\r\nNote: BMI is also defined in the Schedule 1 - Dictionary."
    } ]
  }, {
    "paragraph" : "9(27)",
    "text" : "having dyslipidaemia before the clinical worsening of retinal vascular\r\nocclusion",
    "definedTerms" : [ {
      "term" : "dyslipidaemia",
      "definition" : "means persistently abnormal blood lipid levels, diagnosed by a\r\nmedical practitioner and evidenced by:\r\n(a) a total serum cholesterol level greater than 5.5 mmol/L; or\r\n(b) a serum low density lipoprotein level greater than 4.0 mmol/L; or\r\n(d) a serum triglyceride level greater than or equal to 2.0 mmol/L; or\r\n(e) the regular administration of drug therapy to normalise blood lipid\r\nlevels."
    } ]
  }, {
    "paragraph" : "9(28)",
    "text" : "having hyperhomocysteinaemia before the clinical worsening of retinal\r\nvascular occlusion",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(29)",
    "text" : "having an arteritis from the specified list of systemic arteritides, at the\r\ntime of the clinical worsening of retinal vascular occlusion",
    "definedTerms" : [ {
      "term" : "specified list of systemic arteritides",
      "definition" : "means:\r\n(a) giant cell (temporal) arteritis;\r\n(b) polyarteritis nodosa;\r\n(c) Takayasu arteritis; or\r\n(d) thromboangiitis obliterans (Buerger's disease)."
    } ]
  }, {
    "paragraph" : "9(30)",
    "text" : "having retinal vasculitis at the time of the clinical worsening of retinal\r\nvascular occlusion",
    "definedTerms" : [ {
      "term" : "retinal vasculitis",
      "definition" : "means inflammation of the retinal artery or its branches, or\r\nthe retinal vein or its tributaries. Retinal vasculitis can be due to autoimmune\r\ndisease, infection, drugs, or may be idiopathic. It can be confined to the\r\nretinal vessels, or may be an element of a systemic vasculitis.\r\nNote 1: Autoimmune diseases that can cause  include:\r\n(a) Behcet disease;\r\n(b) eosinophilic granulomatosis with polyangiitis (EGPA);\r\n(c) granulomatosis with polyangiitis (Wegener granulomatosis);\r\n(d) microscopic polyangiitis;\r\n(e) polyarteritis nodosa;\r\n(f) Susac syndrome;\r\n(g) systemic lupus erythematosus; and\r\n(h) systemic sclerosis (scleroderma).\r\nNote 2: Infections that can cause  include:\r\n(a) cytomegalovirus;\r\n(b) herpes simplex virus;\r\n(c) human immunodeficiency virus;\r\n(d) syphilis;\r\n(e) toxoplasmosis;\r\n(f) tuberculosis;\r\n(g) varicella zoster virus; and\r\n(h) viral uveitis.\r\nNote 3: Drug-induced causes of  include intravitreal vancomycin and intraocular\r\ngentamycin."
    } ]
  }, {
    "paragraph" : "9(31)",
    "text" : "having a non-inflammatory vasculopathy of the cerebral or retinal\r\nvessels from the specified list of vasculopathies at the time of the\r\nclinical worsening of retinal vascular occlusion",
    "definedTerms" : [ {
      "term" : "specified list of vasculopathies",
      "definition" : "means:\r\n(a) fibromuscular dysplasia;\r\n(b) Moyamoya disease; or\r\n(c) Sneddon syndrome."
    } ]
  }, {
    "paragraph" : "9(32)",
    "text" : "having a disorder that is associated with a hypercoagulable state or\r\nhyperviscosity at the time of the clinical worsening of retinal vascular\r\nocclusion",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(33)",
    "text" : "having:\r\n(a) a benign or malignant neoplasm; or\r\n(b) a non-neoplastic mass lesion;\r\nwhich compresses or infiltrates the retinal vessels of the affected eye at\r\nthe time of the clinical worsening of retinal vascular occlusion;\r\nNote 1: Examples of a benign or malignant neoplasm include astrocytoma, optic nerve\r\nmeningioma, leukaemia and lymphoma.\r\nNote 2: Examples of a non-neoplastic mass lesion include haematoma, sarcoidosis,\r\nneurofibromatosis and exophthalmos",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(34)",
    "text" : "having a vascular abnormality of the retinal vessels of the affected eye\r\nat the time of the clinical worsening of retinal vascular occlusion",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(35)",
    "text" : "having migraine at the time of the clinical worsening of retinal vascular\r\nocclusion",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(36)",
    "text" : "having infection with human immunodeficiency virus before the\r\nclinical worsening of retinal vascular occlusion",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(37)",
    "text" : "having an ocular or orbital infection involving the affected eye within\r\nthe 30 days before the clinical worsening of retinal vascular occlusion;\r\nNote 1: Examples of an ocular or orbital infection include:\r\n(a) cat scratch disease;\r\n(b) herpes zoster ophthalmicus;\r\n(c) ocular tuberculosis; and\r\n(d) orbital abscess or cellulitis.\r\nNote 2: This excludes isolated conjunctivitis or blepharitis of the affected eye",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(38)",
    "text" : "having direct external pressure to the eyeball of the affected eye for a\r\ncontinuous period of at least ten minutes, within the 24 hours before\r\nthe clinical worsening of retinal vascular occlusion;\r\n(a) surgery in the prone position;\r\n(b) surgery involving the use of a device that compresses the eyes; and\r\n(c) positioning that places direct mechanical pressure on the eye",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(39)",
    "text" : "having a blunt or penetrating injury involving the affected eye or the\r\nblood vessels supplying or draining the affected eye, including surgery\r\nor a therapeutic procedure, within the seven days before the clinical\r\nworsening of retinal vascular occlusion;\r\nNote 1: In the case of prolonged unconsciousness associated with trauma, the seven day period\r\nis taken to commence upon regaining consciousness.\r\nNote 2: Examples of blunt or penetrating injury include:\r\n(a) blunt trauma to the orbit;\r\n(b) eyeball contusion; and\r\n(c) intraocular foreign body.\r\nNote 3: Examples of surgery or a therapeutic procedure include:\r\n(a) cataract surgery;\r\n(b) filler injection to the forehead, or the glabellar, nasal or nasolabial fold regions;\r\n(c) intraocular or retrobulbar anaesthesia;\r\n(d) intravitreal bevacizumab injection; and\r\n(e) sclerotherapy of facial veins",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(40)",
    "text" : "taking a drug from the specified list of drugs within the 72 hours before\r\nthe clinical worsening of retinal vascular occlusion",
    "definedTerms" : [ {
      "term" : "specified list of drugs",
      "definition" : "means:\r\n(a) amphetamines and amphetamine-like compounds;\r\n(b) cannabis;\r\n(c) intranasal cocaine;\r\n(d) intravenous heroin contaminated with talc;\r\n(e) phosphodiesterase type 5 (PDE5) inhibitors;\r\n(f) testosterone supplementation; or\r\n(g) tranexamic acid."
    } ]
  }, {
    "paragraph" : "9(41)",
    "text" : "taking a combined oral contraceptive pill for a continuous period of at\r\nleast 21 days within the one year before the clinical worsening of\r\nretinal vascular occlusion",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(42)",
    "text" : "experiencing an acute hypotensive episode within the 24 hours before\r\nthe clinical worsening of retinal vascular occlusion",
    "definedTerms" : [ {
      "term" : "acute hypotensive episode",
      "definition" : "means a sudden drop in blood pressure of a\r\nsufficient degree to cause cerebral hypoperfusion."
    } ]
  }, {
    "paragraph" : "9(43)",
    "text" : "for retinal venous occlusion only:\r\n(a) having open-angle glaucoma, angle-closure glaucoma or ocular\r\nhypertension, at the time of the clinical worsening of retinal\r\nvascular occlusion;\r\n(b) having chronic renal failure at the time of the clinical worsening\r\nof retinal vascular occlusion;\r\n(c) being severely dehydrated at the time of the clinical worsening\r\nof retinal vascular occlusion; or\r\n(d) having obstructive sleep apnoea at the time of the clinical\r\nworsening of retinal vascular occlusion",
    "definedTerms" : [ {
      "term" : "chronic renal failure",
      "definition" : "means:\r\n2\r\n(a) having a glomerular filtration rate of less than 15 mL/min/1.73 m for a\r\nperiod of at least three months; or\r\n(b) a need for renal replacement therapy (dialysis or transplantation) for\r\ntreatment of complications of decreased glomerular filtration rate\r\nwhich would otherwise increase the risk of morbidity and mortality; or\r\n(c) undergoing chronic dialysis.\r\ndisorder that is associated with a hypercoagulable state or hyperviscosity\r\nmeans an acquired defect in blood components that alters blood viscosity or\r\ndisrupts the coagulation cascade, characterised by an increased predisposition\r\nto form blood clots.\r\nNote: Examples of a disorder that is associated with a hypercoagulable state or hyperviscosity include:\r\n(a) antiphospholipid antibody syndrome;\r\n(b) lymphoplasmacytic leukaemia;\r\n(c) lymphoplasmacytic lymphoma (Waldenstrom macroglobulinaemia);\r\n(d) myeloma;\r\n(e) myeloproliferative neoplasm;\r\n(f) nephrotic syndrome;\r\n(g) paroxysmal nocturnal haemoglobinuria; and\r\n(h) polycythaemia."
    }, {
      "term" : "being severely dehydrated",
      "definition" : "means having clinical dysfunction due to\r\ninadequate body fluids, in which the loss of body fluids, mostly water,\r\nexceeds intake. Symptoms and signs of severe dehydration include limited\r\nor absent urine output, dizziness or lightheadedness, and orthostatic\r\nhypotension.\r\nNote: Examples of causes of dehydration include strenuous physical activity, vomiting, diarrhoea and\r\nfebrile illness."
    } ],
    "conditionVariant" : {
      "name" : "retinal venous occlusion",
      "variantFactors" : [ {
        "paragraph" : "(a)",
        "text" : "having open-angle glaucoma, angle-closure glaucoma or ocular\r\nhypertension, at the time of the clinical worsening of retinal\r\nvascular occlusion"
      }, {
        "paragraph" : "(b)",
        "text" : "having chronic renal failure at the time of the clinical worsening\r\nof retinal vascular occlusion"
      }, {
        "paragraph" : "(c)",
        "text" : "being severely dehydrated at the time of the clinical worsening\r\nof retinal vascular occlusion"
      }, {
        "paragraph" : "(d)",
        "text" : "having obstructive sleep apnoea at the time of the clinical\r\nworsening of retinal vascular occlusion"
      } ]
    }
  }, {
    "paragraph" : "9(44)",
    "text" : "for retinal arterial occlusion only:\r\n(a) having carotid artery disease at the time of the clinical worsening\r\nof retinal vascular occlusion;\r\n(b) having a cardiac disease with the potential to give rise to a\r\nretinal embolus at the time of the clinical worsening of retinal\r\nvascular occlusion;\r\n(a) acute myocardial infarction;\r\n(b) atrial fibrillation; and\r\n(c) mitral or aortic valve disease.\r\n(c) having a non-cardiac potential source of retinal embolus at the\r\ntime of the clinical worsening of retinal vascular occlusion; or\r\n(a) aortic arch atherosclerosis;\r\n(b) atherosclerotic central retinal artery;\r\n(c) decompression sickness;\r\n(d) deep vein thrombosis in the presence of a potential route of paradoxical\r\nembolism;\r\n(e) pulmonary barotrauma; and\r\n(f) severe bone trauma.\r\n(d) undergoing a procedure to the heart or the carotid artery, or an\r\nintravascular procedure involving the vessels of the head or\r\nneck, within the seven days before the clinical worsening of\r\nretinal vascular occlusion;\r\nNote 1: Examples of a procedure to the heart include:\r\n(a) cardiac surgery or cardiac catheterisation;\r\n(b) coronary angiography; and\r\n(c) coronary artery bypass grafting.\r\nNote 2: Examples of a procedure to the carotid artery include:\r\n(a) carotid angioplasty;\r\n(b) carotid endarterectomy; and\r\n(c) carotid stenting.\r\nNote 3: Examples of an intravascular procedure involving the vessels of the head or\r\nneck include:\r\n(a) cosmetic vein sclerotherapy to the orbital adnexa, face, nose or sinuses;\r\n(b) transcatheter thyroid artery embolisation; and\r\n(c) transfemoral cerebral angiography",
    "definedTerms" : [ ],
    "conditionVariant" : {
      "name" : "retinal arterial occlusion",
      "variantFactors" : [ {
        "paragraph" : "(a)",
        "text" : "having carotid artery disease at the time of the clinical worsening\r\nof retinal vascular occlusion"
      }, {
        "paragraph" : "(b)",
        "text" : "having a cardiac disease with the potential to give rise to a\r\nretinal embolus at the time of the clinical worsening of retinal\r\nvascular occlusion"
      }, {
        "paragraph" : "(a)",
        "text" : "acute myocardial infarction"
      }, {
        "paragraph" : "(b)",
        "text" : "atrial fibrillation; and"
      }, {
        "paragraph" : "(c)",
        "text" : "mitral or aortic valve disease."
      }, {
        "paragraph" : "(c)",
        "text" : "having a non-cardiac potential source of retinal embolus at the\r\ntime of the clinical worsening of retinal vascular occlusion"
      }, {
        "paragraph" : "(a)",
        "text" : "aortic arch atherosclerosis"
      }, {
        "paragraph" : "(b)",
        "text" : "atherosclerotic central retinal artery"
      }, {
        "paragraph" : "(c)",
        "text" : "decompression sickness"
      }, {
        "paragraph" : "(d)",
        "text" : "deep vein thrombosis in the presence of a potential route of paradoxical\r\nembolism"
      }, {
        "paragraph" : "(e)",
        "text" : "pulmonary barotrauma; and"
      }, {
        "paragraph" : "(f)",
        "text" : "severe bone trauma."
      }, {
        "paragraph" : "(d)",
        "text" : "undergoing a procedure to the heart or the carotid artery, or an\r\nintravascular procedure involving the vessels of the head or\r\nneck, within the seven days before the clinical worsening of\r\nretinal vascular occlusion;\r\nNote 1: Examples of a procedure to the heart include:"
      }, {
        "paragraph" : "(a)",
        "text" : "cardiac surgery or cardiac catheterisation"
      }, {
        "paragraph" : "(b)",
        "text" : "coronary angiography; and"
      }, {
        "paragraph" : "(c)",
        "text" : "coronary artery bypass grafting.\r\nNote 2: Examples of a procedure to the carotid artery include:"
      }, {
        "paragraph" : "(a)",
        "text" : "carotid angioplasty"
      }, {
        "paragraph" : "(b)",
        "text" : "carotid endarterectomy; and"
      }, {
        "paragraph" : "(c)",
        "text" : "carotid stenting.\r\nNote 3: Examples of an intravascular procedure involving the vessels of the head or\r\nneck include:"
      }, {
        "paragraph" : "(a)",
        "text" : "cosmetic vein sclerotherapy to the orbital adnexa, face, nose or sinuses"
      }, {
        "paragraph" : "(b)",
        "text" : "transcatheter thyroid artery embolisation; and"
      }, {
        "paragraph" : "(c)",
        "text" : "transfemoral cerebral angiography"
      } ]
    }
  }, {
    "paragraph" : "9(45)",
    "text" : "inability to obtain appropriate clinical management for retinal vascular\r\nocclusion",
    "definedTerms" : [ ]
  } ]
}